These courses are intended for internal hospital staff.

Activity Description:

Address standards of care issues and educate physicians on best practices. Facilitate inter-professional collaboration, discussion, and evidence-based case review related to clinical indications for surgery, treatment plans, and interventions for patients with spine injuries and conditions. Provide updates in technology, evidence based medicine and review past cases for improvements in patient outcomes. 

Target Audience: 

Medical Oncologists, Radiation Oncologists, General Surgeons, Orthopaedic, Pathologists, Radiologists, Pharmacists, Nurses, Social Workers, Radiologic Technologists, Patient Care Facilitators 

Learning Objectives: 

1. Identify discordant, complex, or rare molecular and histopathological findings and describe how these findings may impact treatment approach.
2. Review therapeutic agents and treatment strategies and incorporate these into management of sarcoma patients discussed, including on-label, new/emerging, clinical trial, and off-label options where clinically indicated.
3. Improve communication and the collaborative performance of the multidisciplinary oncology care team in the management of sarcoma patients

Moderator:     

John Barker, MD

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.